Breaking Down the Science of Longevity: A Discussion with Healthspan's Founder and CEO, Daniel, on the Wise Athletes Podcast

In a recent episode of the Wise Athletes Podcast, Healthspan's founder and CEO, Daniel, shared his story. He talked about how his research on mTOR-driven aging and his wife's lymphoma relapse led him to create Healthspan. Daniel also explained the scientific research that informs the rapamycin protocol offered by Healthspan.In the podcast, he discusses:

• His background in studying mTOR inhibitors as potential interventions for neurodegenerative diseases.

• How his wife's lymphoma relapse pushed him to start a telemedicine clinic focused on mTOR dysfunction, cellular senescence, and metabolic dysfunction.

• The three fates of a damaged cells and how damaged senescent cells compound tissue decline over time.

• Dr. Mikhail Blagosklonny's foundational theory of cellular hyperfunctions and its implications for mTOR-driven aging and the usage of rapamycin.

• Exploring the relationship between mTOR overactivity and anabolic resistance, and examining the potential benefits of using rapamycin to restore sensitivity to muscle growth stimuli.

• The safety profile of rapamycin—what the Mannick study tells us about rapamycin and immune function and what the blood test of Healthspan's patients on the rapamycin protocol reveals.

• The limitations of anti-aging drugs and the importance of lifestyle interventions to increase healthspan.

Please check out the Wise Athlete Podcast. You can listen to the podcast on the following platforms:

• The Wise Athletes Website

• Apple Podcasts

• Spotify

• Google Podcasts